Dear Ministry of Business, Innovation & Employment,

1. Please detail all funding paid from the Callaghan Fund whether in grants, loans, cash or otherwise to any of Heliase Nominees Limited, Heliase Genomics Limited, Heliase Analytics Limited or Heliase Limited?

2. Please provide a copy of the application by the recipient of the funding (Heliase Nominees Limited, Heliase Genomics Limited, Heliase Analytics Limited or Heliase Limited) and any correspondence pertaining to it.

3. Heliase Limited was recently restored on the Companies Register on 27th April 2016. Heliase Limited is the 100% shareholder of Heliase Genomics Limited and the two other subsidiary companies named above (Heliase Nominees Limited and Heliase Analytics Limited). Heliase Genomics according to the report was represented on a Callaghan Innovation Fund mission to Washington in June 2015.

See report - https://callaghaninnovation.wordpress.co...

a) Is it within the rules of funding from the Callaghan Fund to allow companies whose shareholder (or itself) is removed on the Companies Register, or anticipated to be at the time, to be funded, and;
b) for it to be represented on such trips with the Callaghan Fund?

4. Is the Callaghan Fund aware that a recipient of funds has a shareholder that has only recently had its status restored on the Companies Register after being removed from 29th January 2016? Or if Heliase Limited was the recipient of the funds that itself was removed and restored on the Register?

5. Gabriel James of Heliase Genomics Limited was representative of the company on the trip aforementioned according to the report. Please detail any official report available under the OIA of his attendance on this trip including correspondences prior to the trip that discussed the criteria for his attendance.

Yours faithfully,

Paul Robinson